Valeant picks up nutraceuticals; E.U. says MabThera is bacteria free;

 @FiercePharma: Watson asks for FDA approval on generic Testim, Auxilium's testosterone drug. Auxilium sues (of course). Story | Follow @FiercePharma

> Valeant Pharmaceuticals ($VRX) is acquiring some assets from nutraceutical-maker Swiss Herbal Remedies. Item

> Genericsmaker Mylan ($MYL) has settled a patent suit with Sunovion Pharmaceuticals over the the Japanese drugmaker's bronchitis medicine Brovana. Item

> Mylan also is now offering in the U.K. and Italy its generic version of the Roche ($RHHBY) osteoporosis tablet Bonviva. Release

> Pharmaceutical compounder Franck's Pharmacy, which earlier issued a series of recalls of specific products, has now issued what it calls an "urgent" recall of all of its sterile human and veterinary products because FDA inspectors found fungus and microorganisms in the sterile room. Story

>  The FDA has given the thumbs up to Sun Pharmaceutical to sell its generic version of Medpointe Pharm"s Astelin nasal spray for allergies. Item


Biotech News

 @FierceBiotech: FDA panel mixed on Pfizer's rare disease drug. More | Follow @FierceBiotech

 @RyanMFierce: Bloomberg: After dubious Sirtris deal, Glaxo has targeted partners in recent M&As. Report | Follow @RyanMFierce

 @JohnCFierce: EMA recommends Vertex's Kalydeco for cystic fibrosis population. Item | Follow @JohnCFierce

> Elan boss: Climate improved for Alzheimer's drugs. Article

> Sangart stashes $50M funding for oxygenation drugs. News

> GSK gambles on biotech partners after dubious M&A deal. More

Medical Devices News

 @FierceMedDev: The Senate passed the FDA user fee bill 96-1, a move praised by members of the device industry. Story | Follow @FierceMedDev

 @MarkHFierce: Folks, there's still time to submit your nominations for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce

> FCC approves spectrum bandwidth for medical devices. Report

> Led by Medtronic, hypertension devices could pay big in the U.S. News

> NEJM study: IUDs, implants prevent more unwanted pregnancies. More

> MIT concocts next-generation, needle-free drug injector. Article


And Finally... E.U. regulators say Roche's blockbuster cancer drug MabThera is safe to take because the Leptospira licerasiae bacteria found at its U.S. factory in early batches, which were tossed, was not found in later-stage batches. Story